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Background
Heparin binding epidermal growth factor like growth fac-
tor (HB-EGF) is a member of the epidermal growth factor
family. The role of HB-EGF in cardiovascular disease such
as atherosclerosis has been well-reported but its perti-
nence to cerebrovascular disease including hydrocephalus
is unknown. In our laboratory human HB-EGF transgenic
mice have been observed to demonstrate communicating
hydrocephalus. The goal of this study was to find any dif-
ference in expression of three genes in vascular-lining cells
under varying concentration of this growth factor.
Materials and methods
Two cell groups of murine microvascular endothelial and
non-endothelial cell were exposed to 10, 100, and 1000
ng/ml of recombinant human HB-EGF (rhHB-EGF). Cel-
lular response to rhHB-EGF was examined by quantitative
real time reverse transcription polymerase chain reaction
focusing on mRNA expression of vascular endothelial
growth factor (VEGF), transforming growth factor β1
(TGF-β1), and tumor necrosis factor α (TNF-α), that may
be associated with hydrocephalus. Also, VEGF protein lev-
els in the culture supernatants of these cells to rhHB-EGF
were measured by enzyme linked immunosorbent assay.
Results
The results indicated that VEGF mRNA was significantly
increased by 3–5 fold in endothelial cells treated with
rhHB-EGF relative to the untreated control (p < 0.05). As
compared to the control, mRNA expression of TNF-α in
endothelial cells was significantly increased by 3, 9, and
13 fold at 12 h following 10, 100, and 1000 ng/ml of
rhHB-EGF treatment, respectively (p < 0.05). Also, TGF-β1
mRNA in non-endothelial cells was significantly elevated
by 4, 6, and 7 fold at 24 h following introduction of 10,
100, and 1000 ng/ml of rhHB-EGF, respectively (p <
0.05). When exposed to rhHB-EGF, VEGF protein levels in
the conditioned media of endothelial cells were detecta-
ble but those in non-endothelial groups were undetecta-
ble over 1–6 h period.
Conclusion
These data demonstrated that rhHB-EGF led to induction
of VEGF and TNF-α in microvascular endothelial cells and
upregulation of TGF-β1 in non-endothelial cells from
murine origin. Our findings support a hypothesis that
human HB-EGF could activate multiple mouse genes
reportedly linked to hydrocephalus and that it is worth-
while to assay these factors in cerebrospinal fluid of ani-
mal models for hydrocephalus.
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